» Articles » PMID: 35111883

Prevalence of Mental Health Conditions Among 6078 Individuals With Down Syndrome in the United States

Overview
Specialty Health Services
Date 2022 Feb 3
PMID 35111883
Authors
Affiliations
Soon will be listed here.
Abstract

Findings from a recent study of the largest documented cohort of individuals with Down syndrome (DS) in the United States described prevalence of common disease conditions and strongly suggested significant disparity in mental health conditions among these individuals as compared with age- and sex-matched individuals without DS. The retrospective, descriptive study reported herein is a follow-up to document prevalence of 58 mental health conditions across 28 years of data from 6078 individuals with DS and 30,326 age- and sex-matched controls. Patient data were abstracted from electronic medical records within a large integrated health system. In general, individuals with DS had higher prevalence of mood disorders (including depression); anxiety disorders (including obsessive-compulsive disorder); schizophrenia; psychosis (including hallucinations); pseudobulbar affect; personality disorder; dementia (including Alzheimer's disease); mental disorder due to physiologic causes; conduct disorder; tic disorder; and impulse control disorder. Conversely, the DS cohort experienced lower prevalence of bipolar I disorder; generalized anxiety, panic, phobic, and posttraumatic stress disorders; substance use disorders (including alcohol, opioid, cannabis, cocaine, and nicotine disorders); and attention-deficit/hyperactivity disorder. Prevalence of many mental health conditions in the setting of DS vastly differs from comparable individuals without DS. These findings delineate a heretofore unclear jumping-off point for ongoing research.

Citing Articles

Neurodevelopmental Abnormalities in Down Syndrome: Assessing Structural and Functional Deficits.

Robinson J, Chawla N, Patel S, Spey E, McNulty O, Kaur G Cureus. 2025; 16(12):e76156.

PMID: 39845250 PMC: 11750628. DOI: 10.7759/cureus.76156.


Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorder.

Santoro J, Jafarpour S, Keehan L, Khoshnood M, Kazerooni L, Boyd N Sci Rep. 2024; 14(1):30865.

PMID: 39730779 PMC: 11680819. DOI: 10.1038/s41598-024-81819-8.


Proposed Physiological Mechanisms Underlying the Association between Adverse Childhood Experiences and Mental Health Conditions: A Narrative Review.

Kurbatfinski S, Dosani A, Dewey D, Letourneau N Children (Basel). 2024; 11(9).

PMID: 39334644 PMC: 11430311. DOI: 10.3390/children11091112.


Trisomy 21 and Congenital Heart Disease: Impact on Health and Functional Outcomes From Birth Through Adolescence: A Scientific Statement From the American Heart Association.

Peterson J, Clarke S, Gelb B, Kasparian N, Kazazian V, Pieciak K J Am Heart Assoc. 2024; 13(19):e036214.

PMID: 39263820 PMC: 11681493. DOI: 10.1161/JAHA.124.036214.


Case report: Down syndrome regression disorder, catatonia, and psychiatric and immunomodulatory interventions.

Connors M, Sachdev P, Colebatch J, Taylor M, Trollor J, Mohan A Front Psychiatry. 2024; 15:1416736.

PMID: 39132313 PMC: 11316268. DOI: 10.3389/fpsyt.2024.1416736.


References
1.
Ekstein S, Glick B, Weill M, Kay B, Berger I . Down syndrome and attention-deficit/hyperactivity disorder (ADHD). J Child Neurol. 2011; 26(10):1290-5. DOI: 10.1177/0883073811405201. View

2.
Coppus A, Evenhuis H, Verberne G, Visser F, Oostra B, Eikelenboom P . Survival in elderly persons with Down syndrome. J Am Geriatr Soc. 2008; 56(12):2311-6. DOI: 10.1111/j.1532-5415.2008.01999.x. View

3.
Vicari S, Pontillo M, Armando M . Neurodevelopmental and psychiatric issues in Down's syndrome: assessment and intervention. Psychiatr Genet. 2013; 23(3):95-107. DOI: 10.1097/YPG.0b013e32835fe426. View

4.
Smith D . Health care management of adults with Down syndrome. Am Fam Physician. 2001; 64(6):1031-8. View

5.
Glasson E, Sullivan S, Hussain R, Petterson B, Montgomery P, Bittles A . The changing survival profile of people with Down's syndrome: implications for genetic counselling. Clin Genet. 2002; 62(5):390-3. DOI: 10.1034/j.1399-0004.2002.620506.x. View